| National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID … JM Gelfand, AW Armstrong, S Bell, GL Anesi, A Blauvelt, C Calabrese, ... Journal of the American Academy of Dermatology 84 (5), 1254-1268, 2021 | 112 | 2021 |
| National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: Version 1 JM Gelfand, AW Armstrong, S Bell, GL Anesi, A Blauvelt, C Calabrese, ... Journal of the American Academy of Dermatology 83 (6), 1704-1716, 2020 | 57 | 2020 |
| Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: a population-based study JM Gelfand, J Wan, H Zhang, DB Shin, A Ogdie, MN Syed, A Egeberg Journal of the American Academy of Dermatology 84 (6), 1636-1643, 2021 | 39 | 2021 |
| Machine learning applications in the evaluation and management of psoriasis: a systematic review K Yu, MN Syed, E Bernardis, JM Gelfand Journal of Psoriasis and Psoriatic Arthritis® 5 (4), 147-159, 2020 | 36 | 2020 |
| Risk of herpesvirus, serious and opportunistic infections in atopic dermatitis: a population‐based cohort study J Wan, DB Shin, MN Syed, K Abuabara, AR Lemeshow, JM Gelfand British Journal of Dermatology 186 (4), 664-672, 2022 | 24 | 2022 |
| The risk of respiratory tract infections in psoriasis patients treated with IL-23-pathway inhibiting biologics: a meta-estimate of pivotal trials relevant to decision-making … MN Syed, DB Shin, MT Wan, KL Winthrop, JM Gelfand J Am Acad Dermatol 83, 1523-1526, 2020 | 21* | 2020 |
| Association of apremilast with vascular inflammation and cardiometabolic function in patients with psoriasis: the VIP-A Phase 4, open-label, nonrandomized clinical trial JM Gelfand, DB Shin, AW Armstrong, SK Tyring, A Blauvelt, S Gottlieb, ... JAMA dermatology 158 (12), 1394-1403, 2022 | 18 | 2022 |
| Evaluation of the frequency of “not relevant” responses on the Dermatology Life Quality Index by sociodemographic characteristics of patients with psoriasis JS Barbieri, DB Shin, MN Syed, J Takeshita, JM Gelfand JAMA dermatology 156 (4), 446-450, 2020 | 16 | 2020 |
| Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 … MN Syed, M Shah, DB Shin, MT Wan, KL Winthrop, JM Gelfand Journal of the American Academy of Dermatology 84 (1), 161-163, 2021 | 13 | 2021 |
| Prophylactic antibiotics versus immunoglobulin replacement in specific antibody deficiency J Hajjar, AL Nguyen, G Constantine, C Kutac, MN Syed, JS Orange, ... Journal of Clinical Immunology 40, 158-164, 2020 | 13 | 2020 |
| Atopic dermatitis and risk of major neuropsychiatric disorders in children: a population‐based cohort study J Wan, DB Shin, MN Syed, K Abuabara, AR Lemeshow, JM Gelfand Journal of the European Academy of Dermatology and Venereology 37 (1), 114-122, 2023 | 12 | 2023 |
| Malignancy risk in patients with atopic dermatitis: a population-based cohort study J Wan, DB Shin, MN Syed, K Abuabara, AR Lemeshow, ZCC Fuxench, ... British Journal of Dermatology 189 (1), 53-61, 2023 | 10 | 2023 |
| Risk factors of Pneumonia in primary antibody deficiency patients receiving immunoglobulin therapy: data from the US Immunodeficiency Network (USIDNET) MN Syed, C Kutac, JM Miller, R Marsh, KE Sullivan, ... Journal of Clinical Immunology 42 (7), 1545-1552, 2022 | 6 | 2022 |
| Neuropsychiatric disorders in adults with atopic dermatitis: A population‐based cohort study J Wan, S Wang, DB Shin, MN Syed, K Abuabara, AR Lemeshow, ... Journal of the European Academy of Dermatology and Venereology 38 (3), 543-548, 2024 | 4 | 2024 |
| Quality appraisal of educational websites about osteoporosis and bone health MA Lopez-Olivo, JKA des Bordes, MN Syed, A Alemam, A Dodeja, ... Archives of Osteoporosis 16, 1-6, 2021 | 4 | 2021 |
| Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis ZCC Fuxench, J Wan, S Wang, MN Syed, DB Shin, K Abuabara, ... JAMA dermatology 159 (10), 1085-1092, 2023 | 3 | 2023 |
| Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis J Wan, ZCC Fuxench, S Wang, MN Syed, DB Shin, K Abuabara, ... The Journal of Allergy and Clinical Immunology: In Practice 11 (10), 3123 …, 2023 | 3 | 2023 |
| Atopic dermatitis and risk for headache disorders and migraines: a population-based cohort study in children and adults from the UK ZCC Fuxench, J Wan, S Wang, MN Syed, DB Shin, K Abuabara, ... British Journal of Dermatology 190 (1), 120-123, 2024 | 2 | 2024 |
| Incident Asthma, Asthma Exacerbations, and Asthma-Related Hospitalizations in Patients With Atopic Dermatitis J Wan, S Wang, DB Shin, MN Syed, K Abuabara, AR Lemeshow, ... The Journal of Allergy and Clinical Immunology: In Practice 12 (2), 421-430. e1, 2024 | 1 | 2024 |
| 32607 Risk of cardiovascular events and all cause mortality in patients with atopic dermatitis: A population-based cohort study MN Syed, DB Shin, J Wan, K Abuabara, AR Lemeshow, JM Gelfand Journal of the American Academy of Dermatology 87 (3), AB202, 2022 | 1 | 2022 |
Joel M. Gelfand MD MSCEJames J Leyden Professor of Dermatology and EpidemiologyVerified email at uphs.upenn.edu
